- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · May 1, 2025 | 17.6M sh |
| Long Term Debt | Q2 2025 · Mar 31, 2025 | $27.4M |
| Long Term Debt | Q2 2025 · Sep 30, 2024 | $28.03M |
| Cash And Equivalents | Q2 2025 · Mar 31, 2025 | $1.23M |
| Cash And Equivalents | Q2 2025 · Sep 30, 2024 | $538.98K |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $8.52M |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $7.27M |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $36.37M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $35.74M |
| Current Assets | Q2 2025 · Mar 31, 2025 | $41.46M |
| Current Assets | Q2 2025 · Sep 30, 2024 | $34.69M |
| Total Assets | Q2 2025 · Mar 31, 2025 | $89.89M |
| Total Assets | Q2 2025 · Sep 30, 2024 | $82.38M |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 17.49M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 17.48M sh |
| Capex | Q2 2025 · Mar 31, 2024 | $308.65K |
| Operating Cash Flow | Q2 2025 · Mar 31, 2024 | $4.42M |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $41.38M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $39.9M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $38.64M |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.07 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.13 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.07 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.13 |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $2.91M |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $5.92M |
| Rd Expense | Q2 2025 · Mar 31, 2024 | $1.03M |
| Rd Expense | Q2 2025 · Mar 31, 2024 | $1.93M |
| Net Income | Q2 2025 · Mar 31, 2024 | $1.21M |
| Net Income | Q2 2025 · Mar 31, 2024 | $2.27M |
| Net Income | Q2 2025 · Dec 31, 2023 | $1.06M |
| Operating Income | Q2 2025 · Mar 31, 2024 | $1.64M |
| Operating Income | Q2 2025 · Mar 31, 2024 | $3.26M |
| Gross Profit | Q2 2025 · Mar 31, 2024 | $5.58M |
| Gross Profit | Q2 2025 · Mar 31, 2024 | $11.11M |
| Cost Of Revenue | Q2 2025 · Mar 31, 2024 | $5.16M |
| Cost Of Revenue | Q2 2025 · Mar 31, 2024 | $8.94M |